Aradyme Development Corp. Enters Strategic Partnership to Accelerate Practice Management Sales.Business Editors/Health/Medical Writers/High-Tech Writers AMERICAN FORK, Utah--(BUSINESS WIRE)--July 2, 2003 Aradyme Corp. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :ADYE) announced today that its subsidiary, Aradyme Development Corp., signed an agreement with Clinically Speaking, Inc., a veteran of the medical practice field. Clinically Speaking, Inc. has been actively involved in sales, service and consulting for 20 years, with a focus on medical practice management and technology solutions to increase productivity, while reducing the liability of today's busy medical practitioner. The terms of this agreement have Clinically Speaking assuming the responsibilities for managing content and direction in the advancement of Aradyme's practice management solution to include a fully integrated scheduler and Electronic Medical Records (EMR (ElectroMagnetic Radiation) The emanation of energy from everything in the universe. Although the EMR from electrical and electronic devices is typically measured for practical, every-day situations, every object, including humans, emanates energy. ). "With the unbelievable flexibility Aradyme offers, we see huge potential in this market space for Aradyme and Clinically Speaking to capture major market share as doctors and their practices grow increasingly concerned about how to automate their practices," stated Robert Murri Murri can refer to any of following:
In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. fully integrated solutions so they can focus on caring for their patients," concluded Murri. Clinically Speaking also has a network of sales people who are experienced in selling technology solutions to the medical field. This network will be used to introduce Aradyme's application to the industry and has the potential of doing millions of dollars of sales annually. "It is anticipated that this relationship will also result in additional revenue opportunities from software modules developed by Aradyme and Clinically Speaking that can easily and quickly be fully integrated in practices running Aradyme's base application," stated James Spencer James Spencer may refer to:
The financial terms of the agreement were not made available at the time of this release, but it is know that the two companies will be sharing revenue on a sliding scale slid·ing scale n. A scale in which indicated prices, taxes, or wages vary in accordance with another factor, as wages with the cost-of-living index or medical charges with a patient's income. that naturally creates an incentive for Clinically Speaking to ramp sales as fast as possible. Aradyme Development Corp. is a "Next Generation" database platform company. It develops and distributes integrated software solutions that help companies manage and grow their businesses. It uses proprietary technology to rapidly build integrated database applications in a drag-and-drop environment that are more powerful, flexible and yet more affordable than today's leading alternatives. Aradyme-based solutions remain flexible to real-time additions, modifications and changes, allowing applications to continually evolve real-time with business processes. Aradyme is currently involved in custom application development in a variety of business sectors and markets. "Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " Statement Under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: Information in this release is subject to uncertainties relating to market conditions, the technology, business plan, market opportunities and other contingencies. The company undertakes no obligation to update information contained in this release. For further information regarding risks and uncertainties associated with the company's business, please refer to the "Risk Factors" section of the company's SEC filings. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion